Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Article | IMSEAR | ID: sea-223675

ABSTRACT

Background & objectives: BK virus (BKV) is a polyomavirus and cause of a common infection after renal transplantation which could be preceded to BKV-associated nephropathy. It has four main subtypes (I–IV). BKV subtypes II and III are rare, whereas subtype I shows a ubiquitous distribution. The objective of the present study was to investigate the prevailing BKV subtypes and subgroups in renal transplant patients in Sri Lanka. Methods: The presence of BKV in urine was tested through virus load quantification by real-time PCR from 227 renal transplant patients who were suspected to have BKV infection. Of these patients only 41 were found to be BKV infected (>103copies/ml) and those were subjected to conventional PCR amplification of VP1 gene followed by BKV genotyping via phylogenetic analysis based on DNA sequencing data. Results: Persistent BK viral loads varied from 1×103 to 3×108 copies/ml. Of the 41 patient samples, 25 gave positive results for PCR amplification of subtyping region of VP1 gene of BKV. BKV genotyping resulted in detecting subtype I in 18 (72%) and subtype II in seven (28%) patients. BKV subgroups of Ia, Ib-1 and Ib-11, and Ic were identified with frequencies of 6/18 (33.3%), 6/18 (33.3%), 5/18 (27.8%), and 1/18 (5.6%), respectively. Interpretation & conclusions: Findings from this preliminary study showed a high occurrence of subtype I, while the presence of subtype II, which is rare and less prevalent, was a novel finding for this Asian region. This emphasizes the need for further molecular and serological studies to determine the prevalence of different BKV subtypes in Sri Lanka

2.
Acta Medica Philippina ; : 347-352, 2020.
Article in English | WPRIM | ID: wpr-979851

ABSTRACT

Background@#Human Pegivirus (HPgV), previously called Hepatitis G virus or GB virus C, is an RNA virus. It can be transmitted vertically (mother to infant), parenterally and sexually. HPgV share common routes of transmission to other viruses such as Hepatitis B virus, Hepatitis C virus and Human Immunodeficiency virus (HIV) thus co-infection is usually observed. Risk groups of HPgV include injection drug users, HIV-positive individuals, multi-transfused patients, hemodialysis patients, hemophiliacs, chronic liver disease patients and organ transplant recipients. The clinical significance of HPgV is not yet established and warrants further studies. Research on HPgV in the Philippines is scarce and has not been updated for over 10 years. There is no published data on HPgV prevalence in Filipino pediatric population specifically among risk groups like multi-transfused children with decompensated liver disease secondary to biliary cirrhosis and liver transplant pediatric patients. The lack of local data warrants conduct of this study. @*Objective@#To determine the presence of HPgV RNA, HPgV E2 antibody (anti-E2) and HBsAg among Filipino children with decompensated liver disease secondary to biliary cirrhosis (DBC) and liver transplant pediatric patients (LTP).@*Methods@#Included were 15 children with DBC and 15 LTP recruited from the Section of Pediatric Gastroenterology, Hepatology and Nutrition of the UP PGH. All patients’ sera were tested for HPgV RNA by Real Time RT-PCR, HPgV anti-E2 by Enzyme-linked Immunosorbent Assay (ELISA) and hepatitis B surface antigen (HBsAg) by immunochromatographic test. Twenty age and sex matched children with no history of liver disease and blood transfusion served as controls. @*Results@#All patient and control samples were negative for HPgV RNA. HPgV anti-E2 was detected in 6 of 15 LTP, 5 of 15 DBC and 1 of 20 controls. HBsAg was detected in 2 of 15 LTP, 5 of 15 DBC and 0 of 20 controls. Four patients (two LTP, two DBC) were positive for both HPgV anti-E2 and HBsAg. @*Conclusion@#This study showed that a proportion of liver transplant patients and those with decompensated biliary cirrhosis are positive for HPgV anti-E2, which indicates that these individuals previously had HPgV infection but is now resolved. Possible source of infection is infected blood from the blood transfusions, infected transplant organ or infected mother. Since routine HPgV screening is not yet recommended for the general population, blood donors and organ donors, the confirmation of exact source of infection may be difficult. Co-infection with HBsAg was also observed in both risk groups which suggests that at some point in time, these children were infected by both HPgV and HBV and also the possibility of simultaneous infection by the two viruses. This study provides preliminary data on the proportion of HPgV infection in Filipino children belonging to two of the HPgV risk groups. Studies with a larger and more significant sample size to determine HPgV prevalence as well as studies regarding the pathogenicity of HPgV are warranted. As this may provide basis for routine HPgV screening among risk groups and blood donations in the future.


Subject(s)
GB virus C
3.
Rev. chil. infectol ; Rev. chil. infectol;36(5): 656-662, oct. 2019. tab, graf
Article in Spanish | LILACS | ID: biblio-1058092

ABSTRACT

Resumen La criptococosis es una micosis sistémica producida por un hongo levaduriforme encapsulado denominado Cryptococcus neoformans. Es una enfermedad universal, que ocurre con mayor frecuencia en pacientes inmunocomprometidos, manifestándose principalmente como una enfermedad diseminada con compromiso meníngeo o pulmonar. Sin embargo, la osteomielitis ocurre solo en 5-10% de los casos, siendo el compromiso vertebral el más frecuente. Presentamos un caso de criptococosis vertebral aislada y una búsqueda bibliográfica sobre el tema. Se recomienda realizar una terapia antifúngica de inducción intravenosa y continuar con una fase de consolidación, vía oral, de duración variable. La indicación quirúrgica se considera en lesiones que comprometen la estabilidad vertebral y aquellas que presentan un compromiso neurológico, producen deformidad y para reducir el inóculo infeccioso.


Cryptococcosis is an infectious disease caused by a ubiquitous encapsulated yeast called Cryptococcus neoformans, it is usually associated with immunosuppressed patients. Osteomyelitis occurs in 5-10%, the spine involvement is one of the most reported. The purpose of this work is to present a case of isolated vertebral cryptococcosis and detail the results of a literature review. The treatment protocol is not yet established but it is recommended to start with aggressive intravenous therapy and continue with a suppressive treatment orally during a variable time. Surgical indication is considered in lesions that affect the spinal stability, deformity or neurological compromise and for local infectious control.


Subject(s)
Humans , Male , Aged , Osteomyelitis/microbiology , Osteomyelitis/pathology , Spinal Diseases/microbiology , Spinal Diseases/pathology , Cryptococcosis/pathology , Osteomyelitis/diagnostic imaging , Spinal Diseases/diagnostic imaging , Biopsy , Magnetic Resonance Imaging , Tomography, X-Ray Computed , Cryptococcosis/diagnostic imaging , Cryptococcus/isolation & purification
4.
Rev. argent. microbiol ; Rev. argent. microbiol;48(2): 110-118, jun. 2016. graf, tab
Article in English | LILACS | ID: biblio-843156

ABSTRACT

High levels of circulating EBV load are used as a marker of post-transplant lymphoproliferative disorders (PTLD). There is no consensus regarding the threshold level indicative of an increase in peripheral EBV DNA. The aim of the study was to clinically validate a developed EBV quantification assay for early PTLD detection. Transversal study: paired peripheral blood mononuclear cells (PBMC), plasma and oropharyngeal lymphoid tissue (OLT) from children undergoing a solid organ transplant with (n = 58) and without (n = 47) PTLD. Retrospective follow-up: 71 paired PBMC and plasma from recipients with (n = 6) and without (n = 6) PTLD history. EBV load was determined by real-time PCR. The diagnostic ability to detect all PTLD (categories 1-4), advanced PTLD (categories 2-4) or neoplastic PTLD (categories 3 and 4) was estimated by analyzing the test performance at different cut-off values or with a load variation greater than 0.5 log units. The higher diagnostic performance for identifying all, advanced or neoplastic PTLD, was achieved with cut-off values of 1.08; 1.60 and 2.47 log EBV gEq/10(5) PBMC or 2.30; 2.60; 4.47 log gEq/10(5) OLT cells, respectively. EBV DNA detection in plasma showed high specificity but low (all categories) or high (advanced/neoplastic categories) sensitivity for PTLD identification. Diagnostic performance was greater when: (1) a load variation in PBMC or plasma was identified; (2) combining the measure of EBV load in PBMC and plasma. The best diagnostic ability to identify early PTLD stages was achieved by monitoring EBV load in PBMC and plasma simultaneously; an algorithm was proposed.


La carga alta del virus Epstein-Barr se utiliza como un marcador de desórdenes linfoproliferativos postrasplante (post-transplant lymphoproliferative disorders [PTLD]). El objetivo de este estudio fue validar clínicamente un ensayo de cuantificación del virus Epstein-Barr para la detección temprana de PTLD. Se efectuó un estudio transversal en el que se analizaron muestras pareadas de células mononucleares periféricas (CMP), de plasma y de tejido linfoide orofaríngeo de niños con trasplante de órgano sólido, con PTLD (n = 58) y sin PTLD (n = 47). En el seguimiento retrospectivo se incluyeron 71 muestras pareadas de CMP y de plasma de trasplantados, con PTLD (n = 6) y sin PTLD (n = 6). La carga viral se determinó por PCR en tiempo real. Se estimó la capacidad diagnóstica para detectar PTLD (categorías: todas vs. avanzadas vs. neoplásicas) analizando diferentes valores de corte o una variación de carga mayor de 0,5 logaritmos. El mayor desempeño diagnóstico para identificar todos los PTLD, los avanzados y los neoplásicos, se obtuvo con valores de corte de 1,08; 1,60 y 2,47 log copias/10(5) en CMP y de 2,30; 2,60 y 4,48 log copias/10(5) en células de tejido linfoide orofaríngeo, respectivamente. La detección del ADN del virus Epstein-Barr en el plasma mostró una especificidad alta, pero una sensibilidad baja (todas las categorías) o alta (categorías avanzadas o neoplásicas) para identificar PTLD. Se observó el desempeño diagnóstico más alto en las siguientes condiciones: 1) al identificar una variación de carga en CMP o en plasma; 2) combinando la medición de la carga viral en CMP y en plasma. La mejor capacidad diagnóstica para identificar las etapas tempranas de los PTLD se logró mediante el seguimiento simultáneo de la carga viral en CMP y en plasma; se propone un algoritmo.


Subject(s)
Child , Child, Preschool , Humans , Infant , Postoperative Complications/virology , Viremia/diagnosis , Heart Transplantation , Kidney Transplantation , Liver Transplantation , Herpesvirus 4, Human/isolation & purification , Epstein-Barr Virus Infections/virology , Lymphoproliferative Disorders/virology , Postoperative Complications/diagnosis , Postoperative Complications/etiology , DNA, Viral/blood , Leukocytes, Mononuclear/virology , Cross-Sectional Studies , Retrospective Studies , Follow-Up Studies , Immunocompromised Host , Viral Load , Epstein-Barr Virus Infections/diagnosis , Early Detection of Cancer , Real-Time Polymerase Chain Reaction , Lymphoid Tissue/virology , Lymphoma/diagnosis , Lymphoma/etiology , Lymphoma/virology , Lymphoproliferative Disorders/diagnosis , Lymphoproliferative Disorders/etiology
5.
Mem. Inst. Oswaldo Cruz ; 108(1): 119-122, Feb. 2013. graf, tab
Article in English | LILACS | ID: lil-666056

ABSTRACT

Human respiratory syncytial virus (HRSV) causes severe infections among children and immunocompromised patients. We compared HRSV infections among Haematopoietic Stem Cell Transplant program (HSCT) patients and children using direct immunofluorescence (DFA), point-of-care RSV Bio Easy® and a polymerase chain reaction (PCR) assay. Overall, 102 samples from HSCT patients and 128 from children obtained positivity rate of 18.6% and 14.1% respectively. PCR sensitivity was highest mainly on samples collected after five days of symptoms onset. A combination of both DFA and reverse transcriptase-PCR methods for HSCT high-risk patients is the best diagnostic flow for HRSV diagnosis among these patients.


Subject(s)
Adolescent , Adult , Aged , Child , Child, Preschool , Humans , Infant , Infant, Newborn , Middle Aged , Young Adult , Hematopoietic Stem Cell Transplantation/adverse effects , Respiratory Syncytial Virus Infections/diagnosis , Respiratory Syncytial Virus, Human/genetics , Brazil/epidemiology , Fluorescent Antibody Technique, Direct , Hematologic Neoplasms/surgery , Nasopharynx/virology , Reverse Transcriptase Polymerase Chain Reaction , RNA, Viral/analysis , Respiratory Syncytial Virus Infections/epidemiology
6.
Article in Korean | WPRIM | ID: wpr-101818

ABSTRACT

BACKGROUND: Kidney transplant patient have a higher quality of life (QOL) and consume fewer health care resources compared to patients on dialysis. The purposes of this study were to compare the QOL in transplant patients and dialysis patients, and to provide basic materials necessary for enhancing their perceived QOL through conducting a survey. METHODS: The subjects of this study were 108 kidney transplant patients performed in our center, from 1990 to 2007, and 46 dialysis patients. These data have been collected from August to September in 2007 by a structured questionnaire about QOL consists of 42 items that assess 6 aspects; Affective state, Social activities, Somatic symptoms, family relationship and financial situation, attitudes toward life, and perceptions of health. We analyzed the collected data through T-test, frequency analysis, and one way ANOVA by employing a statistics package, SPSS 12.0 and we used Cronbach's Alpha Coefficient to verify accuracy and reliability of the measurement tools. RESULTS: Kidney transplant patients were shown statistically significant higher QOL than the dialysis patients, in affective state (P=.000), social activities (P=.001), somatic symptoms (P=.000), attitudes toward life (p=.000), and perceptions of health (P=.000). In family relationship and financial situation (P=.202), transplant patients were shown higher scores than dialysis patients, but there were not statistically significant differences. CONCLUSIONS: We suggest that kidney transplant patients enjoy higher QOL than dialysis patients with statistically significant differences, and there also showed different levels of the QOL according to general characteristics and disease-related features between the two types of patients.


Subject(s)
Humans , Delivery of Health Care , Dialysis , Family Relations , Kidney , Quality of Life , Surveys and Questionnaires , Transplants
7.
Article in Korean | WPRIM | ID: wpr-148105

ABSTRACT

PURPOSE: Cardiovascular disease is a substantial health problem in renal transplant patients, and ischemic heart disease is a leading cause of death in these patients. Renal transplant patients have many conventional risk factors for atherosclerotic coronary artery diaese, including hypertension, hyperlipidemia, and posttransplant diabetes mellitus. This study were to evaluate the prevalence of angiographically-determined coronary artery occlusive disease (CAOD) in renal transplant patients, and to identify the risk factors for significant coronary artery disease. METHODS: The retrospective study were performed in 36 patients with renal transplantation who underwent coronary angiography to diagnose ischemic heart disease. RESULTS: A total of 36 recipients (27 males, 9 females) were studied and the mean age was 51.5 years. Significant CAOD was identified in 69% of patients (1-vessel: 19%, 2: 25, 3: 25). By univariate and multivariate logistic regression analysis, the association of clinical variables with CAOD was assessed. The interval between the diagnosis of end-stage renl disease and renaltransplantation was an independent risk factor (P<0.05). The variables such as old age, acute rejection episodes, cholesterol level, as well as the presence of obesity, and D.M,. were not associated. CONCLUSION: The prevalence of angiographically-determined CAOD in renal transplant recipients is 69%. The risk of CAOD seems to be increased in recipients with long duration of dialysis before transplantation. The early or preemptive transplantation could be recommended for preventing CAOD in renal transplantation candidates.


Subject(s)
Humans , Male , Cardiovascular Diseases , Cause of Death , Cholesterol , Coronary Angiography , Coronary Artery Disease , Coronary Vessels , Diabetes Mellitus , Diagnosis , Dialysis , Hyperlipidemias , Hypertension , Kidney Transplantation , Logistic Models , Myocardial Ischemia , Obesity , Prevalence , Retrospective Studies , Risk Factors , Transplantation
8.
Article in Korean | WPRIM | ID: wpr-34849

ABSTRACT

Cytomegalovirus(CMV) infection in normal adults and children is usually asymptomatic. However, CMV represents a potent opportunistic pathogen in immunocompromised hosts, such as neonate, victims of acquired immune deficiency syndrome, organ transplant recipients, and patients receiving immunosuppressive chemotherapy, in whom the virus is capable of causing severe morbidity and mortality. We report three cases of CMV retinitis in the kedney transplat. patients who had been treated with immunosuppressants after transplant.


Subject(s)
Adult , Child , Humans , Infant, Newborn , Acquired Immunodeficiency Syndrome , Cytomegalovirus Retinitis , Cytomegalovirus , Drug Therapy , Immunocompromised Host , Immunosuppressive Agents , Kidney , Mortality , Retinitis , Transplants
SELECTION OF CITATIONS
SEARCH DETAIL